Affluent Medical SA (AFME.PA)

1.6350 +0.0350 (+2.19%) At close: 11:26AM CEST

Affluent Medical SA

320, avenue Archimède
Les Pléiades III – Bâtiment B
Aix-en-Provence 13100
France
33 4 42 95 12 20
https://www.affluentmedical.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Sebastien Ladet Ph.D.	Chief Executive Officer	N/A	N/A	N/A
Christophe de Vregille	Chief Financial Officer	N/A	N/A	N/A
Ms. Celine Buard	Marketing Director	N/A	N/A	N/A
Melanie Cantal	Human Resources Manager	N/A	N/A	N/A
Prof. Francois Laborde M.D., Ph.D.	Chief Surgical Officer	N/A	N/A	N/A
Mr. Olivier Pierron	Deputy Chief Executive Officer	N/A	N/A	1969
Mr. Benjamin Renault Ph.D.	Chief Development Officer	N/A	N/A	N/A
Dr. Christophe Giot M.D.	Chief Medical Officer & VP of Clinical Affairs	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Affluent Medical SA develops minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is based in Aix-en-Provence, France.

Corporate governance

Affluent Medical SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.